Gossamer Bio (GOSS) Income towards Parent Company (2022 - 2025)
Historic Income towards Parent Company for Gossamer Bio (GOSS) over the last 4 years, with Q3 2025 value amounting to -$48.2 million.
- Gossamer Bio's Income towards Parent Company fell 5654.64% to -$48.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$158.8 million, marking a year-over-year decrease of 11324.01%. This contributed to the annual value of -$56.5 million for FY2024, which is 6856.36% up from last year.
- Latest data reveals that Gossamer Bio reported Income towards Parent Company of -$48.2 million as of Q3 2025, which was down 5654.64% from -$38.3 million recorded in Q2 2025.
- In the past 5 years, Gossamer Bio's Income towards Parent Company registered a high of $49.2 million during Q2 2024, and its lowest value of -$59.0 million during Q3 2022.
- In the last 4 years, Gossamer Bio's Income towards Parent Company had a median value of -$44.7 million in 2024 and averaged -$39.8 million.
- As far as peak fluctuations go, Gossamer Bio's Income towards Parent Company skyrocketed by 21585.09% in 2024, and later crashed by 17774.01% in 2025.
- Gossamer Bio's Income towards Parent Company (Quarter) stood at -$57.2 million in 2022, then rose by 15.85% to -$48.1 million in 2023, then surged by 31.4% to -$33.0 million in 2024, then tumbled by 46.0% to -$48.2 million in 2025.
- Its last three reported values are -$48.2 million in Q3 2025, -$38.3 million for Q2 2025, and -$39.3 million during Q1 2025.